Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Celldex Therapeutics buy UBS Group AG

Celldex Therapeutics
Start price
€25.38
10.06.26 / 50%
Target price
€38.97
10.06.27
Performance (%)
40.07%
Price
€35.57
10.08.26
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Celldex Therapeutics has seen massive gains of 40.07%. This prediction currently runs until 10.06.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Celldex Therapeutics 9.379% 9.379%
iShares Core DAX® 1,00 % 4,83 %
iShares Nasdaq 100 2,70 % -1,72 %
iShares Nikkei 225® 3,52 % -3,51 %
iShares S&P 500 1,77 % 1,27 %

Comments by UBS_Group_AG for this prediction

In the thread Celldex Therapeutics diskutieren
Prediction Buy
Perf. (%) 40.07%
Target price 38.966
Change
Ends at 10.06.27

Celldex Therapeutics (CLDX) had its price target raised by UBS Group AG from $38.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for CLDX provided by MarketBeat

UBS Group AG 
0
Report Share
10.06.26